Because Experience Matters
At Siron Clinical we couldn’t be prouder of our rich history, and the accolades and accomplishments that define our business and help us to stand out as a local CRO with a global mindset.
2000
Siron Clinical founded, and Head Office opened in the Netherlands.
2004
Siron Clinical starts a collaboration with a Swiss biotech startup.
2005
A Swiss biotech startup realized receiving extended approval for its first IMP in PAH. Siron Clinical was responsible for regulatory support and clinical monitoring for two studies used in the submission dossier.
2008
Started a new collaboration with a US biotech startup.
2012
Siron Clinical secures a track record of 50 clinical studies in various disease indications.
2014
35 Clinical research professionals join the Siron Clinical team.
2016
US Biotech receive first IMP approval in both the US and EU for PBC.
2016
Sites in Belgium and Italy successfully complete FDA and EMA inspections. Siron Clinical is responsible for regulatory submissions and clinical monitoring.
2017
Siron Clinical Group is created, with a legal presence in Belgium and Germany.
2018
Siron Clinical listed in Pharma Tech Outlook.
2019
EU sites participated in an orphan indication study for which Siron Clinical was responsible for regulatory submission and clinical monitoring. The study successfully completed EMA/FDA inspection.
2020
Siron Clinical launches a brand and business refresh with a new website.
2022
Siron Clinical expands its collaborations in an IIT oncology study to include Israel and Spain.
2024
Siron Clinical continued its collaboration with a Lymphoma Study Group and will be responsible for clinical monitoring in the UK and Nordic region.
2024
Siron Clinical will be exhibiting at the Scope Summit Europe and BioFit 2024.
Experience Matters
As an international contract research organization (CRO), we offer unparalleled knowledge, support, guidance, and experienced clinical research professionals to the biotechnology, life science, and medical device industries. We are committed to leading the development of new and advanced treatments by offering a range of CRO clinical trial services, from Customizable FSP to full-service.